Nephrocare Healt

  • Market Cap: Mid Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
513.65
-6.1 (-1.17%)
BSENSE

Feb 03

BSE+NSE Vol: 1.12 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationUpcoming Result: Nephrocare Healt will declare its result soon on 10 Feb 2026
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.12 lacs (-11.21%) Volume

Shareholding (Dec 2025)

FII

9.30%

Held by 20 FIIs

DII

3.48%

Held by 9 DIIs

Promoter

63.85%

Why is Nephrocare Health Services Ltd falling/rising?

03-Feb-2026

As of 02-Feb, Nephrocare Health Services Ltd's stock price is 520.05, reflecting a 0.32% increase. The stock has outperformed the Sensex significantly over various time frames, although there has been a slight decline in investor participation.

As of 02-Feb, Nephrocare Health Services Ltd is experiencing a rise in its stock price, currently at 520.05, which reflects an increase of 1.65 or 0.32%. This upward movement is supported by several factors. Over the past week, the stock has gained 2.14%, significantly outperforming the Sensex, which only increased by 0.16%. In the last month, Nephrocare's stock has risen by 9.27%, while the Sensex has declined by 4.78%. Year-to-date, the stock has shown a robust performance with a 10.83% increase compared to the Sensex's drop of 4.17%.<BR><BR>Additionally, the stock is trading close to its 52-week high, being only 2.81% away from the peak of Rs 534.65. It is also performing well against its sector, having outperformed it by 0.69% today. The stock is trading above its moving averages across various time frames, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a strong bullish trend.<BR><BR>However, it is important to note that there has been a decline in investor participation, with the delivery volume dropping by 7.97% against the 5-day average. Despite this, the stock remains liquid enough for trading, suggesting that the current rise is supported by positive market sentiment and performance metrics, even amidst a slight decrease in trading volume.

View full answer

Which are the latest news on Nephrocare Healt?

03-Feb-2026
No latest news for Nephrocare Healt found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 5,221 Cr (Mid Cap)

stock-summary
P/E

77.00

stock-summary
Industry P/E

56

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

11.74%

stock-summary
Price to Book

9.13

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

stock-summary
BOARD MEETING

10 Feb 2026

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
4.40
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
17.40%
ROCE (avg)
4.47%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
77
Industry P/E
56
Price to Book Value
9.01
EV to EBIT
54.57
EV to EBITDA
30.84
EV to Capital Employed
9.13
EV to Sales
6.80
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
16.74%
ROE (Latest)
11.74%

Technicals key factors

Indicator
Weekly
Monthly
Icon
No records
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (3.1%)

FIIs

Held by 20 FIIs (9.3%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.92%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Nephrocare Healt"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Nephrocare Healt"
  }
]
stock-summaryCompany CV
About Nephrocare Health Services Ltd stock-summary
stock-summary
Nephrocare Health Services Ltd
Mid Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available